{
  "title": "Melanoma-associated variants tested by MPRAs in melanoma and primary melanocyte cell lines (for more details, see <a target='_blank' rel='noopener noreferrer' href='https://doi.org/10.1016/j.ajhg.2022.11.006'>https://doi.org/10.1016/j.ajhg.2022.11.006</a>)",
  "shortTitle": "Melanoma",
  "columns": [
    {
      "name": "rsid",
      "label": "RSID"
    },
    {
      "name": "Variant.ID.(hg19)",
      "label": "Variant ID (hg19)",
      "description": "chromosome:position (hg19)"
    },
    {
      "name": "GWAS_Locus",
      "label": "GWAS Locus",
      "description": "Melanoma GWAS loci"
    },
    {
      "name": "ref",
      "label": "ref",
      "description": "reference allele"
    },
    {
      "name": "alt",
      "label": "alt",
      "description": "alternative allele"
    },
    {
      "name": "ref_vs_alt_FDR.(UACC903_melanoma)",
      "label": "ref_vs_alt_FDR (UACC903_melanoma)",
      "description": "allelic effect FDR (two-sided Wald test) in UACC903 melanoma cell line"
    },
    {
      "name": "log2_FC_alt.(UACC903_melanoma)",
      "label": "log2_FC_alt (UACC903_melanoma)",
      "description": "log2 fold difference of allelic transcriptional activity normalized to DNA input in UACC903"
    },
    {
      "name": "ref_vs_alt_FDR.(melanocyte)",
      "label": "ref_vs_alt_FDR (melanocyte)",
      "description": "allelic effect FDR (two-sided Wald test) in immortalized human primary melanocytes"
    },
    {
      "name": "log2_FC_alt.(melanocyte)",
      "label": "log2_FC_alt (melanocyte)",
      "description": "log2 fold difference of allelic transcriptional activity normalized to DNA input in melanocytes"
    },
    {
      "name": "Activator.(UACC903_melanoma)",
      "label": "Activator (UACC903_melanoma)",
      "description": "Either allele shows higher normalized expression than the average of all the variants tested in UACC903"
    },
    {
      "name": "Activator.(melanocyte)",
      "label": "Activator (melanocyte)",
      "description": "Either allele shows higher normalized expression than the average of all the variants tested in melanocytes"
    },
    {
      "name": "Cell.type.specificity",
      "label": "Cell type specificity",
      "description": "Based on cell-type-specific MPRA score, activator score, and differentially expressed TF binding affinity"
    },
    {
      "name": "Integrative.score.from.Long.et.al",
      "label": "Integrative score from Long et al",
      "description": "Score combining melanoma/melanocyte MPRA, activator, open chromatin region, histone, FINEMAP/POLYFUN, and motif scores"
    }
  ]
}
